EnglishA pharmaceutical composition containing a compound that binds to active sites of plasmepsin II to inhibit activity, and a method of preventing and treating malaria, including administering an effective dose of the pharmaceutical composition to a mammal. The pharmaceutical composition of the invention contains at least one compound selected from the group consisting of an N- alkoxyamidine derivative, a guanidine derivative, an amide derivative, a urea or thiourea derivative, and N- (2-{[3-(l,3 -benzodioxol- 5 -yl) - 3 -oxo- 1 -propene- 1 -yl] amino } phenyl)-4-nitrobenzene sul¬ fonamide. The compound contained in the pharmaceutical composition is used to prevent and treat malaria since it binds to active sites of plasmepsin II to inhibit activity. The compound is effective to malaria that is resistant to existing anti-malarial drugs.
Pharmaceutical composition for preventing and treating malaria containing compounds that inhibit Plasmepsin II activity, and method of treating malaria using the same / Doman, Kim; Hee Kyoung, Kang; Do Won, Kim; Rastelli, Giulio; Ana Lucia Da, Costa; Vinod, Kasam; Vincent, Breton. - ELETTRONICO. - (2009 Oct 29).
| Data di pubblicazione: | 29-ott-2009 |
| Data di concessione: | 2009 |
| Titolo: | Pharmaceutical composition for preventing and treating malaria containing compounds that inhibit Plasmepsin II activity, and method of treating malaria using the same |
| Autore/i: | Doman, Kim; Hee Kyoung, Kang; Do Won, Kim; Rastelli, Giulio; Ana Lucia Da, Costa; Vinod, Kasam; Vincent, Breton |
| Autore/i UNIMORE: | |
| Abstract: | A pharmaceutical composition containing a compound that binds to active sites of plasmepsin II to inhibit activity, and a method of preventing and treating malaria, including administering an effective dose of the pharmaceutical composition to a mammal. The pharmaceutical composition of the invention contains at least one compound selected from the group consisting of an N- alkoxyamidine derivative, a guanidine derivative, an amide derivative, a urea or thiourea derivative, and N- (2-{[3-(l,3 -benzodioxol- 5 -yl) - 3 -oxo- 1 -propene- 1 -yl] amino } phenyl)-4-nitrobenzene sul¬ fonamide. The compound contained in the pharmaceutical composition is used to prevent and treat malaria since it binds to active sites of plasmepsin II to inhibit activity. The compound is effective to malaria that is resistant to existing anti-malarial drugs. |
| Handle: | http://hdl.handle.net/11380/641926 |
| Enti collegati: | Doman Kim; Hee Kyoung Kang; Do Won Kim; Giulio Rastelli; Ana-Lucia Da Costa; Vinod Kasam; Vincent Breton |
| Rilevanza: | Internazionale |
| Numero di deposito: | WO2009131384 (A2) |
| Tipologia | Brevetto |
File in questo prodotto:
| File | Descrizione | Tipologia | |
|---|---|---|---|
| Description-PCTKR2009002114.pdf | Altro materiale allegato | Administrator Richiedi una copia |
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
Copyright © 2021